Back to Journals » OncoTargets and Therapy » Volume 13

Sequential Infusion of Anti-CD22 and Anti-CD19 Chimeric Antigen Receptor T Cells for a Pediatric Ph-Like B-ALL Patient That Relapsed After CART-Cell and Haplo-HSCT Therapy: A Case Report and Review of Literature [Corrigendum]

Authors Hua J, Qian W, Wu X, Zhou L, Yu L, Chen S, Zhang J, Qiu H

Received 26 March 2020

Accepted for publication 26 March 2020

Published 9 April 2020 Volume 2020:13 Pages 3045—3046

DOI https://doi.org/10.2147/OTT.S255629

Download Article [PDF] 


Hua J, Qian W, Wu X, et al. Onco Targets Ther. 2020;13:2311– 2317.


The authors of this paper have advised that the author and affiliation list on page 2311 is incorrect. The correct author and affiliation list is as follows:

Jingsheng Hua 1,2,*
Weiqing Qian 3,*
Xiaoxia Wu 1,*
Lili Zhou 1
Lei Yu 4
Suning Chen 1
Jian Zhang 1
Huiying Qiu 1

1Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215006, Jiangsu, People’s Republic of China; 2Department of Hematology, Taizhou Municipal Hospital, Taizhou 318000, Zhejiang, People’s Republic of China; 3Suzhou Vocational Health College, Suzhou, Jiangsu, People’s Republic of China; 4College of Chemistry andMolecular Engineering, East China Normal University, Shanghai, People’s Republic of China

*These authors contributed equally to this work

The authors have also advised that the correspondence section on page 2311 is incorrect. The correspondence section should
read as follows:

Correspondence: Huiying Qiu; Jian Zhang
Tel +8613912792913
Fax +8651267781850
Email [email protected]; [email protected]

Read the original article


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]